ImmunoTek Bio Centers Revenue and Competitors

ImmunoTek Bio Centers is an emerging bio-tech company committed to the safe collection and procurement of human blood plasma from the public. The management team has nearly 100 years collective experience in the blood, plasma, and biopharma industries. Through contracts and strategic agreements with pharmaceutical companies, ImmunoTek is fully capable of constructing, opening, FDA/EU licensing, and managing multiple plasma collection sites and plasma supply contracts in order to meet on going demand in the plasma proteins therapeutics market. Growth of current therapeutic drugs and vaccines as well as additional new therapeutic indications expected to put considerable strain on global blood plasma supply. \r\n\r\nThe former Chief Operating Officer, Chief Financial Officer and VP Operations of International BioResources, LLC (â??IBRâ??) formed a new company called ImmunoTek Bio Centers, LLC and acquired the total assets of IBR in November 2012. These assetâ??s included all intellectual property used to operate a plasma collection company e.g: FDA Approved Standard Operating Procedures (â??SOPsâ??), Training Manuals, New Center Development Plans, and all other assets of IBR.